4 Top-Ranked Stocks With Solid Net Profit Margins to Boost Your Gains

Zacks highlights four stocks (FLXS, ARKO, KNSA, BSET) with strong net profit margins as a key profitability screen. Ahead of FY/FY26 earnings, consensus estimates were revised up for each: FLXS +$0.13 to $4.78 (+$0.13 over 60 days), ARKO +$0.03 to $0.29 (+$0.03 over 60 days), KNSA +$0.01 to $1.25 (+$0.01 over 30 days), and BSET +$0.06 to $0.89 (+$0.06 over 7 days). These names also show a recent history of beating consensus in trailing quarters (average surprise: FLXS +59%, ARKO +43.23%, KNSA +1.53%, BSET -6.72%).

Analysis

This screen is more useful as a factor read than as a standalone fundamental call: it flags profitable names with improving estimates, which usually works best over 1-2 quarters when revisions are still moving and the market is rewarding operating leverage. The opportunity is highest where margins are less likely to mean-revert immediately; that makes FLXS the cleanest relative-quality expression in the group, while BSET looks more like a cyclical value name that needs an actual demand turn, not just a screen signal.

The second-order read is that furniture remains a weak end-market, so any outperformance here is likely coming from tighter inventory discipline and pricing, not volume acceleration. That favors a pairs framework long FLXS versus short BSET, because the market is likely to pay up for execution dispersion inside the same category if the next print confirms margin resilience. If housing/rates stay soft, the multiple expansion ceiling is limited and any miss on gross margin would unwind the trade quickly.

ARKO is a different animal: near-term earnings can look good when fuel spreads are favorable, but that is highly transient and can reverse within weeks if wholesale/retail spreads normalize or traffic softens. KNSA is the least screenable name here because biotech margins can be distorted by product mix, reimbursement timing, and launch economics; the real catalyst path is event-driven over 1-3 months, not the margin screen itself. The contrarian risk is that investors overpay for a generic profitability list and ignore how quickly these businesses can revert if the next operating datapoint disappoints.

Key Decisions for Investors

• Long FLXS / short BSET for 6-12 weeks: best relative-quality expression in the set; target 10-15% relative outperformance, invalidate if FLXS gross margin or guide softens.
• Do not chase BSET on the screen alone; treat any strength as an exit opportunity unless there is a confirmed demand inflection or estimate revision cycle over the next quarter.
• ARKO: no standalone long here; only trade it tactically if fuel margins remain elevated into the next earnings window. Falsify the bull case on spread compression or weaker inside-store comps.
• KNSA: stay neutral until a specific catalyst date is visible. If you need exposure, use a call spread into the event rather than stock, since the screen signal is not enough to underwrite durable rerating.
• Set a watch item on the whole basket: if upcoming reports show estimate revisions stopping despite the high margins, fade the theme and rotate out quickly.